Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Cannabinoid treatment for the symptoms of autism spectrum disorder
Adi Aran
*
, Dalit Cayam Rand
*
Corresponding author for this work
Faculty of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cannabinoid treatment for the symptoms of autism spectrum disorder'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Autism Spectrum Disorder
100%
Cannabidiol
100%
Cannabinoid Therapy
100%
Cannabis Extract
42%
Placebo-controlled Study
28%
Autism Spectrum Disorder Symptoms
28%
Clinical Data
14%
Expert Opinion
14%
Area Cover
14%
Mini
14%
Behavioral Patterns
14%
Adverse Events
14%
Childhood Autism
14%
Aripiprazole
14%
Social Communication
14%
Behavioral Deficits
14%
Fragile X Syndrome
14%
Tolerability
14%
Risperidone
14%
School-age children
14%
Pharmacological Treatment
14%
Core Deficit
14%
Placebo-controlled Trial
14%
Repetitive Patterns
14%
Ongoing Clinical Trials
14%
Social Avoidance
14%
Behavioral Challenges
14%
High Safety
14%
Restricted Pattern
14%
Mixed Efficacy
14%
Language Behavior
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid
100%
Autism
100%
Cannabidiol
87%
Cannabis
37%
Placebo-Controlled Study
25%
Adverse Event
12%
Clinical Trial
12%
Placebo
12%
Tolerability
12%
Risperidone
12%
Aripiprazole
12%
Fragile X Syndrome
12%
Diseases
12%